Manufacturers should exhibit that any new technology or strategy not just satisfies the prevailing criteria for sterility assurance and also gives tangible Advantages in terms of performance, trustworthiness, or merchandise security. As these new technologies emerge, the WHO emphasizes the value of a thorough hazard assessment and validation